Optomed ’s co-operation negotiations negotiations have been completed

Report this content

Optomed Plc     Stock Exchange Release             14 April 2020 at 14.15, Helsinki

Optomed’s co-operation negotiations negotiations have been completed

Optomed announced that it commenced co-operation negotiations due to the COVID-19 pandemic on 1 April 2020. The negotiations are now completed. Approximately 50 employees will be laid off part time and only a few employees full time, both for a maximum of 90 days. The part time lay offs apply also to the Group Leadership Team.

The lay offs in combination with other cost saving measures are expected to generate cost savings of approximately half a million Euros in 2020.

Optomed Plc

Further enquiries

Seppo Kopsala, CEO, Optomed Plc, seppo.kopsala@optomed.com

Sakari Knuutti, CLO, Optomed Plc, sakari.knuutti@optomed.com

Optomed in Brief 

Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld screening devices with software and artificial intelligence with the aim to transform the diagnostic process of blinding eye-diseases such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye-screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries. The company has an extensive portfolio of 55 international patents protecting the technology. In 2019, Optomed’s revenue reached EUR 15 million and 2018 pro forma revenue amounted to EUR 14.5 million. At the end of 2019, Optomed employed 108 professionals.